Artificial Intelligence in Histologic Diagnosis of Ductal Carcinoma In Situ
- PMID: 40206631
- PMCID: PMC11975642
- DOI: 10.1016/j.mcpdig.2023.05.008
Artificial Intelligence in Histologic Diagnosis of Ductal Carcinoma In Situ
Abstract
A systematic review was conducted in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocol to evaluate the diagnostic accuracy of artificial intelligence (AI) in ductal carcinoma in situ. Four databases were searched for articles up to December 2022: Embase, PubMed, Scopus, and Web of Science. 23 studies were included, and a search of grey literature was not performed. The following parameters were extracted: the accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of each study. Statistical analysis of the included studies revealed that AI-assisted histopathological analysis is of high accuracy (83.78%), sensitivity (83.88%), and specificity (85.49%) and has a high positive predictive value (89.43%). Our results also reported that convolutional neural network (CNN) is the most commonly used mode of machine learning-21 models used only CNN, whereas 2 models used only support vector machines (SVM). On an average, CNN reported slightly higher accuracy and sensitivity (86.71% and 85.22%, respectively) than SVM (accuracy, 85.00%; sensitivity, 70.00%). When the 2 methods were combined, a mean accuracy of 82.52% and a mean sensitivity of 83.00% were achieved. The use of AI as a diagnostic adjunct can markedly improve the accuracy and efficiency of DCIS diagnosis and can, therefore, reduce pathologists' workload.
© 2023 The Authors.
Conflict of interest statement
The authors report no competing interests.
Figures
References
-
- Breast cancer. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/breast-cancer
-
- Collins L.C., Laronga C., Wong J.S. Breast ductal carcinoma in situ: epidemiology, clinical manifestations, and diagnosis. UpToDate. https://www.uptodate.com/contents/breast-ductal-carcinoma-in-situ-epidem...
-
- Myers D.J., Walls A.L. Atypical breast hyperplasia. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK562244/
-
- Sabel M.S., Collins L.C. Atypia and lobular carcinoma in situ: high-risk lesions of the breast. UpToDate [about 14 screens] https://www.uptodate.com/contents/atypia-and-lobular-carcinoma-in-situ-h...
Publication types
LinkOut - more resources
Full Text Sources